Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L01XE" (19)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Imatinib (L01XE01) 6 products
WHO-DDD
DrugBank.ca
L
IP
CI
Imatinib Devatis 100 mg
(teilbar)
30
231.03
267.65
10 %
Coated tablets: Imatinibum 100 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Imatinib Devatis 100 mg
(teilbar)
60
462.06
518.95
10 %
Coated tablets: Imatinibum 100 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Imatinib Devatis 200 mg
30
430.55
484.65
10 %
Coated tablets: Imatinibum 200 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Imatinib Devatis 200 mg
60
757.78
840.55
10 %
Coated tablets: Imatinibum 200 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Imatinib Devatis 400 mg
30
923.22
1020.45
10 %
Coated tablets: Imatinibum 400 mg
Devatis AG
A / SL / SG
FB
G
L
IP
CI
Imatinib Devatis 400 mg
60
1624.89
1783.60
10 %
Coated tablets: Imatinibum 400 mg
Devatis AG
A / SL / SG
FB
G
Nilotinib (L01XE08) 2 products
WHO-DDD
DrugBank.ca
L
IP
CI
Nilotinib Accord 150 mg
112
938.38
1036.95
10 %
Capsules: Nilotinibum 150 mg
Accord Healthcare AG
A / SL / SG
FB
G
IP
CI
Nilotinib Spirig HC 50 mg
120
k.A.
Capsules: Nilotinibum 50 mg
Spirig HealthCare AG
A
FB
G
Everolimus (L01XE10) 7 products
WHO-DDD
DrugBank.ca
L
IP
CI
Afinitor 10 mg
30 Tablet(s)
1510.79
1640.90
10 %
Tablets: Everolimusum 10 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Votubia 2 mg
30 Tablet(s)
911.01
1007.20
10 %
Dispersible Tablets: Everolimusum 2 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Votubia 3 mg
30 Tablet(s)
1366.51
1502.60
10 %
Dispersible Tablets: Everolimusum 3 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Votubia 2.5 mg
30 Tablet(s)
1138.75
1254.85
10 %
Tablets: Everolimusum 2.5 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Votubia 5 mg
30 Tablet(s)
2202.22
2411.45
10 %
Tablets: Everolimusum 5 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
IP
CI
Afinitor 5 mg
30
1049.49
1144.90
10 %
Tablets: Everolimusum 5 mg
Novartis Pharma
Schweiz AG
SO
FB
G
IP
CI
Afinitor 2.5 mg
30 Tablet(s)
k.A.
Tablets: Everolimusum 2.5 mg
Novartis Pharma
Schweiz AG
A
FB
G
Pazopanib (L01XE11) 3 products
WHO-DDD
DrugBank.ca
L
IP
CI
Votrient 200 mg
30 Tablet(s)
608.03
670.20
10 %
Coated tablets: Pazopanibum 200 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Votrient 400 mg
60 Tablet(s)
2432.00
2631.40
10 %
Coated tablets: Pazopanibum 400 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Pazopanib Sandoz 400 mg
60
1945.60
2132.35
10 %
Coated tablets: Pazopanibum 400 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
Afatinib (L01XE13) 1 products
WHO-DDD
DrugBank.ca
IP
CI
Giotrif 50 mg
28
k.A.
Coated tablets: Afatinibum 50 mg
Boehringer Ingelheim
(Schweiz) GmbH
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
